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Gonadotropin-Releasing Hormone (GnRH) Analogs
or Active Immunization Against GnRH To Control
Fertility in Wildlife
Susan E. Becker and Larry S. Katz

Abstract: The administration of analogs, both agonists and
antagonists, of GnRH and immunization agalnst GnRH have
been investigated for their ability to control reproductive
function in domestic species. These methods can be used
to inhibit the secretion of aonadotro~ins,the necessarv
stimulants for steroidoge;esis and gametogenesis, thereby
~otentiallv~reventinaovulation and inhibitina s~ermatogenesis. .induction of infertility in this manner cbuld be used

for nonlethal population control of wildlife species.
Relatively little research has been done in this area. This
chapter reviews relevant studies with domestic species and
discusses results from studies with wildlife species.
Keywords: gonadotropin-releasing hormone, GnRH
aaonist. GnRH antaaonist. GnRH immunoneutralization
w;ldlik contraception

Introduction
Because hunting and natural mortality cannot control
wildlife populations everywhere, there is increasing
demand for the development of nonlethal methods for
population control of both free-roaming and captive
wildlife. Therefore, fertility control through administration of contraceptive agents is being investigated. The
ideal contraceptive agent should be (1) reversible (for
some species), (2) suitable for remote delivery,
(3) effective with only a single administration, (4) unable
to contaminate the food chain, (5) without harmful side
effects, and (6) without effect on social behavior.
Although steroid hormone treatments have been used
successfully for fertility control in nondomestic animals
(see review by Kirkpatrick and Turner [1991]), the
possibility exists for steroids to enter the food chain. A
nonsteroidal hormone such as gonadotropin-releasing
hormone (GnRH), a small peptide, would not pass
through the food chain because when ingested it
would be cleaved to its constituent amino acids.
Relatively little work has been done to investigate the
effectiveness of GnRH as a contraceptive agent in
nondomestic species.
Gonadotropin-releasing hormone, synthesized in
the hypothalamus of both males and females, is a key
regulator of reproduction in mammals. Released from
the hypothalamus in a pulsatile pattern, it travels via
the portal vasculature to the anterior pituitary, where it
stimulates release of the gonadotropins, luteinizing
hormone (LH), and follicle-stimulating hormone (FSH).
These gonadotropins enter the circulation and regulate both steroidogenesis and gamete maturation in
the gonads (Conn 1994). More specifically, in the

female, FSH stimulates follicular growth and maturation, and LH induces ovulation and corpus luteum
formation. In the male, the direct role for FSH in
spermatogenesis is uncertain, and LH causes the
Leydig cells of the testis to produce testosterone
which is necessary for gametogenesis. FSH, in the
presence of LH, stimulates estradiol production from
both the ovary and the testis. The steroids secreted
from the gonads feed back to the hypothalamus and
pituitary to regulate GnRH and gonadotropin synthesis
and release (see fig. 1).
It is possible to make the pituitary refractory to
GnRH by administering GnRH, or an agonist of GnRH,
in a continuous manner, rather than in the physiological pattern of pulses. Prolonged, continuous infusion
of GnRH, especially at high concentrations, inhibits
gonadotropin secretion (Belchetz et al. 1978), and that
results in loss of gonadal function. Initially, pituitary
desensitization is thought to result from loss of pituitary
cell-surface receptors for GnRH by internalization of
occupied receptors (Conn and Crowley 1991). Later,
as receptor numbers recover due to recycling (Hazum
and Conn 1988) and homologous upregulation (Conn
et al. 1984, Braden and Conn 1990), desensitization
may be maintained because the receptors become
dissociated from their second messenger system
(Conn and Crowley 1991).
Controlling the amount and pattern of GnRH
stimulation to the pituitary affects gonadotropin
synthesis and secretion, thereby affording a potential
method of controlling fertility in both males and
females. Administration of GnRH agonists or antago-
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Figure 1. Pathways of positive (+) and negative (-)feedback of
gonadal steroids on the hypothalamic-pituitary axis in (A) the
female and (B)the male. The effects of estradiol in the female are

positive or negative, depending upon the stage of the estrous
cycle. Question mark (?) indicates relatively insignificant effects

nists, as well as immunization against GnRH, have
been tested for their ability to suppress reproductive
function in humans and domestic animals, yet little
work has been done in this area with wildlife.

GnRH and GnRH Agonists

This results in a delay of effect in both sexes. In
females, this initial increase in gonadotropin secretion
may induce estrus and ovulation, depending upon the
reproductive status of the animal when treatment is
begun. However, if a female were bred during this
induced estrus, the continued administration of GnRH
would likely terminate the pregnancy.

Large doses or chronic administration of GnRH or
GnRH agonists can inhibit gonadotropin secretion by
pituitary desensitization. Agonists are often preferred,
both clinically and experimentally, over GnRH itself
due to their increased potency. In general, they have
a higher binding affinity for the GnRH receptors, are
more resistant to enzymatic degradation, and/or have
a longer half-life in the circulation. Following commencement of treatment with GnRH or its agonists,
there is a transient period of increased gonadotropin
secretion before the suppressive effects of pituitary
desensitization are realized (Conn and Crowley 1991).

In males, there seem to be species differences in
the degree of desensitization possible in response to
GnRH agonists (see review by Vickery [1986]).
Depending upon the species, pituitary desensitization
is not necessarily accompanied by a decline in testosterone secretion and a suppression of spermatogenesis. However, when it is, testosterone supplementation may be necessary if maintenance of normal
sexual behavior in males is desired (Vickery et al.
1984). Given these shortcomings, GnRH agonists
may not be useful as male contraceptives. Nevertheless, they may have some application in control of
androgen-stimulated aggressive behavior.

GnRH Analogs or Active Immunization
Against GnRHTo Control Fertility

In Hawaiian monk seals (Atkinson et al. 1993)
and free-ranging African elephants (Brown et al.
1993), single injections of GnRH agonists have been
tested for their ability to suppress testicular function,
i.e. testosterone production, thereby controlling
aggressive behavior. Male Hawaiian monk seals may
exhibit a breeding behavior called "mobbing" when
their numbers exceed those of the females by more
than 2 3 . The "mobbed" female or immature seal is
severely injured and often dies (Atkinson et al. 1993).
Atkinson and coworkers found that after a transient
increase, serum testosterone concentrations were
reduced to castrate levels for approximately 2 months
in male monk seals following a single injection of a
GnRH agonist. Effects on sexual and aggressive
behavior could not be measured because no female
seals were available.
In the case of African elephants, males go into
musth once or twice a year, during which time they are
dangerously aggressive. Captive elephants in musth
have injured and killed handlers (Brown et al. 1993).
A single injection of a GnRH agonist caused an initial
increase in serum LH and testosterone concentrations
followed by a decline to baseline values. The one bull
which was in musth at the time of treatment did not
appear to be in musth after the decline in serum
testosterone levels. Subsequent challenge with an
intravenous injection of GnRH resulted in an attenuated LH response, suggesting partial desensitization
of the pituitary. However, testosterone secretion was
increased compared with controls, indicating a hypersensitivity to increases in GnRH-induced LH concentrations (Brown et al. 1993).
From these studies it appears that GnRH agonists show promise as agents that may decrease
aggressive behavior by reducing serum concentrations of testosterone. This may be very useful in
captive populations such as those in zoos. Yet it is
important to note that some species, such as cattle,
may respond to chronic treatment with GnRH agonists
with an increase in testicular function, despite depressed pituitary function, as evidenced by elevated
serum testosterone concentrations (Melson et al.
1986).

Another possible outcome of prolonged administration of GnRH agonists is the stimulation of both
pituitary and testicular function, as described by
Lincoln (1987). In that study, red deer stags received
continuous infusion of a GnRH agonist for 72 days
beginning after the rut in winter, a time when the
testes are still secreting significant amounts of testosterone. It was expected that testicular activity would
be suppressed, causing the stags to cast their antlers
prematurely. In fact, treatment with the agonist
resulted in increases in plasma LH and testosterone
concentrations, testes growth, and aggressive behavior, and did not affect time of antler casting. The wide
variation in response of the hypothalamic-pituitarygonadal axis to exogenous GnRH may be due to
several factors, including (1) choice of agonist, (2) dose,
(3) treatment regimen, (4) reproductive status of the
animal, and (5) species. Clearly more research is
needed to determine the usefulness of this approach.
It has been well documented that continuous
treatment with GnRH will suppress gonadotropin
secretion in females (Nett et al. 1981, Adams et al.
1986, Khalid et al. 1989). Inhibition of ovulation
caused by chronic administration of GnRH agonists
has been successful in several species, including
dogs (Vickery et al. 1989), cattle (Herschler and
Vickery 1981), sheep (McNeilly and Fraser 1987),
horses (Montovan et al. 1990), stumptailed monkeys
(Fraser et al. 1980, Fraser 1983), and macaques
(Fraser et al. 1987). We recently attempted to inhibit
secretion of LH in white-tailed deer does (Odocoileus
virginianus) by continually infusing a GnRH analog
(HistrelinTM),with the goal of preventing ovulation
(Becker and Katz 1995).
Briefly, four does received Histrelin at 8.3 kg1
hour subcutaneously via osmotic minipump, for
14 days during the breeding season. Controls were
administered continuous saline infusions (n = 3). On
Day 1 (Day 0 =day of minipump insertion), the
Histrelin-infused group had a higher mean serum LH
concentration than the control group (16.0 i 5.3 v. 0.9
i 0.4 ngImL, respectively). By Day 2, mean LH
concentrations did not differ between the groups and
remained at baseline for the duration of infusion (fig.
2). On Day 10, both groups received a subcutaneous
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injection of 100 pg Histrelin to test the ability of the
pituitary to respond to additional stimulation. At 4 hours
after injection, the mean serum LH concentration for
controls was 17.8 ?r 3.3 ng/mL and was still elevated
at 10 hours. In contrast, serum LH concentrations in
the Histrelin-infused group remained at baseline
(0.5 ?r 0 ng/mL) (fig. 3).
Apparently, continuous infusion of Histrelin
caused pituitary desensitization. It was not possible to
monitor the ovaries ultrasonically; however, serum
progesterone concentrations did not indicate that any
of the four does infused with Histrelin ovulated in
response to the initial rise in serum LH concentrations.
Further research is needed to determine if reproductive status influences whether or not ovulation is
induced (an undesirable side effect) during the transi-

tory increase in serum gonadotropin concentrations.
The practicality of this approach is dependent upon
development of a long-acting, slow-release preparation of agonist that can also be remotely delivered.

GnRH Antagonists
Pituitary suppression may be achieved by administration of antagonists of GnRH, which exert their effects
by competing with endogenous GnRH, preventing
sufficient GnRH occupation of receptors to stimulate
gonadotropin secretion (Conn and Crowley 1991).
The main advantage to using GnRH antagonists
rather than agonists is that pituitary suppression is
immediate. There is no initial increase in gonadotro-
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Figure 2. Effects of continuous administration of Histrelin (8.3 pg/
hour. subcutaneously; n = 4) or saline (confrol; n = 3) on daily
mean serum LH concentrations. Box indicates day of Histrelin
challenqe.
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Figure 3. The LH response to a subcutaneous injection of 100 pg
of Histrelin on Day 10 of the continuous Histrelin in = 4) or
continuous saline in = 3) infuson period (Day 0 = day of implant
insertion). 'denotes treatment difference ( P c 0.05).

GnRH Analogs or Active Immunization
Against GnRHTo Control Fertility

pin secretion, which may stimulate the gonads.
Unfortunately, these drugs are more expensive and
require a higher dosage than the agonists, so they are
best used for short-term treatment or instances where
agonists are not effective (Vickery 1986). In males of
several species, including rats, dogs, and monkeys,
treatment with GnRH antagonists results in a decrease
in serum LH and testosterone concentrations within
hours, and that ultimately halts spermatogenesis
(Vickery 1986). Choice of antagonist may be important, as evidenced by the work of Brown et al. (1993).
They gave a single intramuscular injection of an
antagonist to African elephant bulls that resulted in
reduced basal and GnRH-stimulated serum LH and
testosterone concentrations on Day 2 after injection.
One of the bulls was in musth at the time of treatment
but was no longer in musth by Day 2. In contrast,
treatment of elephant bulls with a different antagonist
of similar structure did not affect pituitary-testicular
function, despite a higher dosage.
Antagonists of GnRH have successfully inhibited
LH secretion and prevented ovulation in several
species, including cattle (Rieger et al. 1989), rats,
dogs, monkeys, and humans (see review by Vickery
119861). For example, weekly subcutaneous injections
for 20 weeks beginning during the midluteal phase of
the estrous cycle resulted in suppression of circulating
LH concentrations (compared with controls), and
inhibition of ovulation throughout the treatment period
in marmoset monkeys (Hodges et al. 1992). This
effect proved to be reversible. Despite these successes, fertility control for wildlife often requires longterm treatment, for which GnRH agonists are better
suited.

lmmunoneutralization of GnRH
Another approach to inhibit gonadotropin secretion
from the pituitary involves active immunization of an
animal against endogenous GnRH. Because GnRH is
a low-molecular weight, naturally occurring peptide, it
is a weak immunogen. It must be adsorbed to a large,
inert particle, such as charcoal, or covalently bound to
a carrier protein, such as a serum albumin, to enhance

immunogenicity. The latter seems to provide more
consistent responses and higher antibody titers (see
review by Jeffcoate and Keeling [1984]). Development of detectable antibody titers in the serum requires many weeks following primary immunization.
Although booster immunizations are not essential for the production of high antibody titers (Adams
and Adams 1992), boosters almost always raise the
existing antibody titers (see review by Schanbacher
[1984]). Once titers are raised, circulating GnRH is
recognized and bound by the anti-GnRH immunoglobulins before it reaches the pituitary, thereby
suppressing LH secretion and usually FSH secretion
(although not always to the same degree) and leading
to an impairment of reproductive function. The degree
of dysfunction appears to be correlated to the GnRH
antibody titer; that is, the higher the titer, the greater
the suppressive effects on reproduction (Lincoln et al.
1982, Safir et al. 1987, Bailie et al. 1989). Unfortunately, immediate inhibition of reproductive function is
not possible unless immunization against GnRH is
passive (administration of GnRH antiserum rather than
a GnRH conjugate functioning as an antigen). For
example, injection of ewes with ovine GnRH antiserum
approximately 10 hours prior to the LH surge prevented the surgc and blocked ovulation (Fraser and
McNeilly 1982). Yet passive immunization ac ins!
GnRH is not a practical method of fertility control
because the effects are not long-lasting (Fraser et al.
1984). Frequent injections of GnRH antisera are not
only impractical but also pose a health threat to the
animal (Schanbacher 1984).
Active immunization against GnRH has successfully suppressed gonadotropin secretion and gonadal
function in a variety of species, including rats and
rabbits (Ladd et al. 1988), pigs (Esbenshade and Britt
1985, Awoniyi et al. 1987), sheep (Clarke et al. 1978,
Adams and Adams 1986), horses (Garza et al. 1986,
Safir et al. 1987), and cattle (Robertson et al. 1982,
Adams and Adams 1990, Adams et al. 1993). However, little work has been done to test the effectiveness of this approach for wildlife. Studies in which red
deer stags were actively immunized against GnRH
met with varying degrees of success (Lincoln et al.
1982, Ataja et al. 1992, Freudenberger et al. 1993).
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Effects on reproductive parameters ranged from a
slight suppression of plasma LH concentrations
compared with controls but no significant reduction of
plasma testosterone concentrations (Ataja et al. 1992)
to a significant decrease in testosterone levels compared with controls, testicular atrophy, and premature
casting of antlers (Lincoln et al. 1982). Differences in
the carrier protein used and the timing of the primary
immunization with respect to reproductive season may
account for this variability. When male and female
wild Norway rats were actively immunized against
GnRH, 100-percent sterility was attained for both
sexes. In the males, testosterone was nondetectable,
and testes were approximately 90-percent atrophied
up to 11 months after vaccination (see Miller, this
volume). Although these results are promising and
immunoneutralizing GnRH is less costly than treatment with either GnRH agonists or antagonists, there
can be large variation in response due to individual
differences in the development of antibody titers.

Conclusion
None of the GnRH-related fertility control methods
described herein meet all of the criteria of the ideal
contraceptive agent outlined previously. One problem
that may apply to any method of contraception in
wildlife is the lack of consensus on the percentage of
animals that must be rendered infertile to bring about
the desired reduction in herd growth rate. Also,
logistical and economic issues pertaining to delivery
systems must be addressed. Perhaps the greatest
problem with GnRH contraception is the resulting
suppression of sexual behavior, which may affect
social behavior and, consequently, social structure.
This problem can be overcome by steroid supplementation using implants, but then food-chain contamination and the need to capture the animals to administer
the treatment become issues that must be considered.
However, inhibition of androgen-stimulated aggressive
behavior may be desired in certain venues, such as
zoos. In addition, care must be taken to ensure that
the contraceptive activity of GnRH analog treatment
lasts throughout the breeding season to avoid young

being born when environmental conditions are unsuitable for offspring survival. Treatment must abolish,
not merely delay, the breeding season. Targeting
GnRH function for contraception of wildlife meets four
of the six criteria mentioned earlier for the ideal
contraceptive agent. Treatment is reversible, suitable
for remote delivery, and unable to contaminate the
food chain. Additionally, single administration is
possible for active immunization against GnRH (and
will be possible for GnRH agonists following the
development of long-lasting, injectable microcapsules). Gonadotropin-releasing hormone contraception should be further investigated for potential
applications in wildlife management.
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